Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XBI vs. BIPIX: which is better?

Bottom line

XBI vs BIPIX: the short answer

XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and BIPIX (Biotechnology Ultrasector Profund) are quite different portfolios: only about 28% of their top holdings (by weight) are shared.

XBI is cheaper at 0.35% vs 1.52% — a difference of $117 a year per $10,000 invested.

Over five years, BIPIX returned +6.1% a year vs −2.7% for XBI (reporting dates differ).

Updated Nov 19, 2026

XBI vs BIPIX side by side

XBIBIPIX
TypeETFMutual fund
Fund familySPDR (State Street)ProShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%1.52%
Annual cost per $10k$35$152
10-yr cost on $10k (prospectus)$443$1,813
Max front loadNone—
12b-1 fee0%0%
1-yr return+35.8%−5.2%
5-yr return (annualized)−2.7%+6.1%
10-yr return (annualized)+5.8%+4.4%
Best quarter+44.4%+35.4%
Worst quarter−26.2%−24.1%
Net assets (fund)$10.7B$118.7M
Number of holdings161159
Portfolio turnover71%52%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXBIBIPIXDifference
2024+1.1%−5.2%+6.3%
2023+7.5%+10.1%−2.6%
2022−25.8%−13.4%−12.3%
2021−20.5%+23.8%−44.3%
2020+48.2%+20.1%+28.1%
2019+32.2%+23.6%+8.6%
2018−14.9%−12.2%−2.7%
2017+43.7%+34.7%+9.0%
2016−15.4%−23.8%+8.3%
2015+13.6%+3.1%+10.5%

Source: Fund prospectus bar charts

Holdings overlap

12 of XBI's top 25 holdings also appear in BIPIX's top 25.

Shared top holdings
HoldingXBIBIPIX
Apogee Therapeutics Inc1.49%1.29%
Twist Bioscience Corp1.41%1.08%
Oruka Therapeutics Inc1.38%1.20%
Kymera Therapeutics Inc1.36%1.05%
Praxis Precision Medicines Inc1.29%1.02%
Erasca Inc1.27%1.08%
Revolution Medicines Inc1.20%1.04%
CG oncology Inc1.20%1.03%
Dianthus Therapeutics Inc1.18%1.12%
Natera Inc1.16%0.99%
Cogent Biosciences Inc1.14%0.99%
Travere Therapeutics Inc1.13%0.95%

Source: SEC Form N-PORT

XBI top 10

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%

BIPIX top 10

  1. N/a — 6.70%
  2. N/a — 5.15%
  3. N/a — 4.12%
  4. N/a — 4.12%
  5. N/a — 3.16%
  6. Agpxx — 2.40%
  7. Apogee Therapeutics Inc — 1.29%
  8. N/a — 1.24%
  9. Oruka Therapeutics Inc — 1.20%
  10. Dianthus Therapeutics Inc — 1.12%

FAQ

What is the difference between XBI and BIPIX?
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and BIPIX (Biotechnology Ultrasector Profund) are quite different portfolios: only about 28% of their top holdings (by weight) are shared. XBI is cheaper at 0.35% vs 1.52% — a difference of $117 a year per $10,000 invested.
Which is cheaper, XBI or BIPIX?
XBI has the lower expense ratio (0.35%).
Should I own both XBI and BIPIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.